A detailed history of Simplex Trading, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 848 shares of ENOB stock, worth $3,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
848
Previous 5,492 84.56%
Holding current value
$3,900
Previous $25,000 88.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
N/A
-4,644 Reduced 84.56%
848 $3,000
Q2 2024

Jul 25, 2024

BUY
N/A
5,492 New
5,492 $25,000
Q4 2023

Feb 02, 2024

BUY
$4.3 - $4.7 $94 - $103
22 Added 29.73%
96 $0
Q3 2023

Nov 01, 2023

BUY
$0.0 - $4.46 $0 - $330
74 New
74 $0
Q2 2022

Aug 03, 2022

BUY
$1.93 - $8.73 $7,158 - $32,379
3,709 Added 559.43%
4,372 $8,000
Q1 2022

May 02, 2022

SELL
$4.42 - $9.0 $4,888 - $9,954
-1,106 Reduced 62.52%
663 $5,000
Q4 2021

Feb 23, 2022

BUY
$6.71 - $12.55 $11,869 - $22,200
1,769 New
1,769 $12,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.